Mercury Biopharmaceutical Other Current Liabilities

The latest other current liabilities for 6932.TWO is $8.6M as of June 2026. That compares with $30M in the prior-year period — down 70.9% year over year. Investors often review this figure alongside Mercury Biopharmaceutical's historical trend and sector peers before judging valuation or financial health.

Over the past year, 6932.TWO's other current liabilities moved from $30M to $8.6M — a 70.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Mercury Biopharmaceutical's operating scale or balance-sheet position.

A other current liabilities figure of $8.6M for 6932.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 6932.TWO's other current liabilities ($8.6M), review year-over-year change from $30M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.